FOR IMMEDIATE RELEASE
BIOSIGN INTRODUCES CLOUD-BASED PLATFORM FOR COMPREHENSIVE OUTPATIENT FACILITIES MANAGEMENT, AT MEDICA 2014
After acquiring AioMed, Canadian manufacturer teams with Caritas, Germany’s largest home and nursing care provider, to develop innovative software suite,
MARKHAM, Ontario, October 22, 2014 – Biosign Technologies Inc. (TSXV: BIO) will return to MEDICA, the world’s largest annual medical trade fair, November 12-15 in Düsseldorf, Germany – armed with new software to meet the world-wide challenges of managing and operating outpatient medical care facilities including nursing homes, extended care homes, and home care agencies.
“We believe our new cloud-based suite changes the whole paradigm of outpatient care of elderly,” says Dr. Michael Gross, CEO of Biosign. “We are now offering the very first platform that provides complete facility and patient management, document management, prescription management, wound management, and social networking – all designed especially for long-term care, nursing home, and extended care providers.”
Since its successful MEDICA debut last year, Biosign has acquired majority control of leading German software developer AioMed GmbH (formerly MECK).
“AioMed (All-in-one Medical) was also attractive because it already had a framework contract with Caritas, which operates 25,000 of its own care facilities and has about 1.2 million employees/helpers and consequently provides 40 per cent of nursing and elderly care in Germany,” explains Dr. Gross. “The management platform developed by AioMed together with Caritas can save organizations like Caritas vast amounts of time and money, while providing higher quality care to patients. It is a platform care providers world-wide will need as they face up to the flood of new patients expected from an aging population, coupled with increasing shortages of doctors.”
Besides its Toronto-area world headquarters and another Canadian base in St. John, New Brunswick, Biosign has offices in New York and Dubai as well German offices in Heidelberg and at the Caritas facility in Buchen.
At MEDICA 2014, Biosign will also feature other products including: its Pulsewave™ vital health signs patient monitor unveiled at MEDICA last year; QCARE with Healthanywhere™, which links with the Pulsewave to provide a remote monitoring solution; as well as ClinicServer, Biosign’s internet-based clinic management software platform.
To learn more about Biosign’s products and services, please visit us during MEDICA at the Ontario, Canada Pavilion, Hall 16, Booth F44 – under the red maple leaf.
Also, you can locate us in “Companies & Products" on the medica-tradefair.com portal.
Biosign Contact: Knut Butzinger
Managing Director, Europe
Biosign Technologies Inc.
Mobile: +49 163 249 4842
Office: +49 6223 86600-14
About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides automated, software enabled health information solutions. The Company's various software divisions, including Clinicserver™ PencilThat™ EESI Corporate Benefits, QLine and AioMed GmbH offer industry-leading allied health clinic and patient-centered care management solutions. For more information on Biosign, please visit www.biosign.com
This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and Biosign's actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. In the context of any forward-looking information please refer to risk factors detailed in, as well as other information contained in the company's filings with Canadian securities regulators (www.sedar.com).
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.